C-UGBRmitochondria transplantation, gene therapy, cellular energy metabolism
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Cellvie states that mitochondria are a foundational product of evolution and central to cellular energy metabolism, youth, and age-related decline, and it believes these organelles can be used as medicines through Therapeutic Mitochondria Transfer to augment or replace damaged mitochondrial function in order to save and restore cellular energy.
Sourcecellvie states that mitochondria are foundational to complex life, central to cellular energy metabolism, and closely tied to both youth and age-related decline. The company believes therapies derived from cells that augment or replace failing mitochondria can reinvigorate cell energy metabolism, establish Therapeutic Mitochondria Transplantation as a new treatment modality, address ischemia-reperfusion injury starting in kidney transplantation, and potentially slow or reverse degenerative aging processes linked to mitochondrial dysfunction.
Sourcecellvie states that it is pioneering Therapeutic Mitochondria Transplantation as a novel treatment approach focused on cellular energy metabolism. The company presents mitochondria as a fundamental product of evolution and the cell's energy-producing machinery, and says it is deriving medicines from cells in order to save and restore function.
Source